Alexandre Tavartkiladze

Prof. Dr. Alexandre Tavartkiladze

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ATAlexandre Tavartkiladze
Alexandre Tavartkiladze
Russel ReiterRussel Reiter
Russel Reiter
RLRuite Lou
Ruite Lou
DKDinara Kasradze
Dinara Kasradze
NONana Okrostsvaridze
Nana Okrostsvaridze
TPTatia Potskhoraia
Tatia Potskhoraia
Melatonin, an indolic neuromodulator with putative oncostatic and proposed anti-inflammatory properties, primarily demonstrated in preclinical models, is produced at extrapineal sites—most notably in the gut. Its canonical actions are mediated by high-affinity GPCRs (MT1/MT2) and by NQO2, a cytosolic enzyme with a melatonin-binding site (historically termed “MT3”). A growing body of work highlights a bidirectional interaction between the gut microbiota and host melatonin. We integrated two lines of work: (i) three clinical cohorts—cardiac arrhythmias (n = 111; 46–75 y), epilepsy (n = 77; 20–59 y), and stage III–IV solid cancers (25–79 y)—profiled with stool 16S rRNA sequencing, SCFA measurements, and circulating melatonin/urinary 6-sulfatoxymelatonin and (ii) an age-spanning cognitive cohort with melatonin phenotyping, microbiome analyses, and exploratory immune/metabolite readouts, including a novel observation of melatonin binding on bacterial membranes. Across all three disease cohorts, we observed moderate-to-severe dysbiosis, with reduced alpha-diversity and shifted beta-structure. The core dysbiosis implicated tryptophan-active taxa (Bacteroides/Clostridiales proteolysis and indolic conversions) and depletion of SCFA-forward commensals (e.g., Faecalibacterium, Blautia, Akkermansia, and several Lactobacillus/Bifidobacterium spp.). Synthesised literature indicates that typical human gut commensals rarely secrete measurable melatonin in vitro; rather, their metabolites (SCFAs, lactate, and tryptophan derivatives) regulate host enterochromaffin serotonin/melatonin production. In arrhythmia models, dysbiosis, bile-acid remodelling, and autonomic/inflammatory tone align with melatonin-sensitive antiarrhythmic effects. Epilepsy exhibits circadian seizure patterns and tryptophan–metabolite signatures, with modest and heterogeneous responses to add-on melatonin. Cancer cohorts show broader dysbiosis consistent with melatonin’s oncostatic actions. In the cognitive cohort, the absence of dysbiosis tracked with preserved learning across ages, and exploratory immunohistochemistry suggested melatonin-binding sites on bacterial membranes in ~15–17% of samples. A unifying microbiota–tryptophan–melatonin axis plausibly integrates circadian, electrophysiologic, and immune–oncologic phenotypes. Practical levers include fiber-rich diets (to drive SCFAs), light hygiene, and time-aware therapy, with indication-specific use of melatonin. Our conclusions regarding microbiota–melatonin crosstalk rely primarily on local paracrine effects within the gut mucosa (where melatonin concentrations are 10–400× plasma levels), whereas systemic chronotherapy conclusions depend on circulating melatonin amplitude and phase. This original research article presents primary data from four prospectively enrolled clinical cohorts (total n = 577).

28 December 2024
Verified
Journal Article
Open access
ATAlexandre Tavartkiladze
Alexandre Tavartkiladze
Jscholar is an open access publisher of peer reviewed journals and research articles, which are free to access, share and distribute for the advancement of scholarly communication.

22 April 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
ATAlexandre Tavartkiladze
Alexandre Tavartkiladze
LTLevan Tavartkiladze
Levan Tavartkiladze
Russel ReiterRussel Reiter
Russel Reiter
Michel BurnierMichel Burnier
Michel Burnier
DKDinara Kasradze
Dinara Kasradze
RTRevaz Turmanidze
Revaz Turmanidze
Background: Circadian desynchronization is increasingly recognized as a transdiagnostic driver of metabolic, neurodegenerative, immune, and oncological pathology. Melatonin, acting primarily through the G-protein-coupled receptors MT1 (MTNR1A) and MT2 (MTNR1B), is the principal endocrine output of the circadian system and exerts pleiotropic oncostatic, antioxidant, and immunomodulatory effects. Whether disrupted melatonin rhythmicity co-segregates with gut dysbiosis, impaired glymphatic clearance, and multi-system biomarker pathology in a clinically identifiable population has not been systematically examined. Aim: To characterize the integrated microbiome–glymphatic–melatonin (MGM) axis in a clinically phenotyped cohort of patients with chronic multisystem symptoms consistent with circadian dysregulation, and to determine whether the resultant biomarker phenotype is age-independent. Methods: We conducted a prospective observational study in 179 patients meeting pre-specified inclusion criteria for circadian dysregulation and 107 practically healthy controls. Circadian melatonin status was assessed using fractionated 24-hour urinary 6-sulfatoxymelatonin (aMT6s) and plasma melatonin at standardized dim-light time windows (daytime 14:00–16:00; nocturnal 02:00–04:00). Microbiome composition was determined by 16S rRNA (V3–V4) sequencing. Urolithin A was quantified by targeted metabolomics. Brain glymphatic function was approximated using the DTI-ALPS index, perivascular spaces scoring, and WMH volumetry. Systemic markers included BNP, CD4/CD8 ratio, and MoCA score. Results: Patients demonstrated a profound collapse of nocturnal melatonin output (aMT6s 10.2 vs 40.6 ng/mL night; Day/Night ratio 0.81 vs 0.14; p< 0.0001 all), constituting a circadian amplitude inversion pattern. Cortisol rhythmicity showed parallel disruption. Microbiome diversity was markedly reduced (Shannon 2.83 vs 5.07), with depletion of urolithin-producing taxa (Gordonibacter, Ellagibacter) and profoundly reduced plasma urolithin A (2.40 vs 25.20 ng/mL). Brain imaging showed elevated WMH volume (9.99 vs 1.54 mL), enlarged perivascular spaces, and reduced DTI-ALPS index (1.05 vs 1.70). Strikingly, MGM-axis biomarkers showed no significant correlation with chronological age within the patient group (Spearman r: −0.10 to +0.09, all p>0.14), indicating age-independent convergence. Conclusions: Circadian desynchronization is associated with a coherent, age-independent MGM-axis phenotype encompassing melatonin amplitude collapse, gut dysbiosis with urolithin A depletion, and imaging markers of impaired brain clearance. This integrated framework identifies tractable multi-domain biomarkers for circadian screening and motivates targeted resynchronization strategies including MT1/MT2-mediated chronotherapy.

Verified
Journal Article
Open access
PDF file
ATAlexandre Tavartkiladze
Alexandre Tavartkiladze
LTLevan Tavartkiladze
Levan Tavartkiladze
GSGaiane Simonia
Gaiane Simonia
Michel BurnierMichel Burnier
Michel Burnier
Russel ReiterRussel Reiter
Russel Reiter
RKRusudan Khutsishvili
Rusudan Khutsishvili
Urolithin A (UA) is a gut microbiota-derived postbiotic generated from dietary ellagitannins, while urinary 6-sulfatoxymelatonin (6-SMT) is a surrogate marker of nocturnal melatonin output. We explored whether dysbiosis, UA depletion, and low 6-SMT define an ordered biomarker pattern across healthy aging, salt-sensitive hypertension, and advanced cancer. In this pilot observational study, patients with advanced solid tumors were classified as Cancer Group 1 (higher aggressiveness; n = 231) or Cancer Group 2 (lower aggressiveness; n = 118) and compared with healthy older controls (n = 117) and elderly participants with salt-sensitive hypertension (n = 333). Plasma UA decreased stepwise from controls (2.24 [1.38–3.12] nmol/L) to salt-sensitive hypertension (1.20 [0.76–1.89] nmol/L), Cancer Group 2 (0.60 [0.32–0.91] nmol/L), and Cancer Group 1, in which most samples were at or below the assay limit (overall p < 0.0001; trend p < 0.0001). Twenty-four-hour urinary 6-SMT declined in parallel, whereas the dysbiosis score, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), interleukin-8 (IL-8), and malondialdehyde (MDA) increased, and antioxidant indices decreased across the ordered groups (all p < 0.0001). These cross-sectional findings support a hypothesis-generating biomarker framework linking dysbiosis, postbiotic depletion, circadian disruption, inflammation, and redox imbalance across age-related disease states.

18 December 2024
Verified
Journal Article
Open access
ATAlexandre Tavartkiladze
Alexandre Tavartkiladze
Jscholar is an open access publisher of peer reviewed journals and research articles, which are free to access, share and distribute for the advancement of scholarly communication.

19 June 2024
Verified
Journal Article
Open access
ATAlexandre Tavartkiladze
Alexandre Tavartkiladze
Despite being widely used in the treatment of various diseases, stem cells still need further study due to their many advantages and disadvantages. The possibility of attaching these cells to damaged organs has encouraged many researchers to understand their use. Stem cells are highly divisible cells that can differentiate into different types of other cells, and some, such as nerve cells, may lose the ability to divide., Jscholar is an open access publisher of peer reviewed journals and research articles, which are free to access, share and distribute for the advancement of scholarly communication.